Friday, July 31, 2026

North Korea’s ‘Suicide Drones’ Revealed: What the Latest Development Means for Global Security

North Korea's "suicide drone" development is part of its five-year defense plan, emphasizing advancements in nuclear technologies.

South Korea Revises Procurement Procedures to Enable Faster Medical Equipment Acquisition in Wartime

South Korea's military can now quickly procure emergency surgical equipment during wartime, streamlining the process for efficiency.

OpenAI Launches Codex Security Plugin: How GPT-5.5-Cyber Enhances Cybersecurity in 2026

OpenAI launches Codex Security plugin and expands Daybreak to enhance AI-driven cybersecurity, addressing vulnerabilities and patching.

Tag: Lotte Biologics

Lotte Biologics’ ‘Three Production Batches, 14% Utilization’ Underscores Need for New Orders Over New Plants

Lotte Biologics aims to enter the global CDMO market by expanding production, but faces challenges in securing contracts and profitability.

Lotte Biologics says it has secured top-10 global CDMO manufacturing capacity [BIO USA]

Lotte Biologics is set to begin commercial production by the end of 2026, advancing its capabilities in the global CDMO market.

Lotte Biologics Wins CDMO Leadership Award… Validates “Quality Management”

Lotte Biologics wins "Best New or Relaunched CDMO" at the 2026 CDMO Leadership Awards, showcasing rapid growth and global recognition.

Lotte Biologics at DCAT Week 2026: Unveiling Strategic Collaborations in Global CDMO

Lotte Biologics will attend DCAT Week in New York to pursue global CDMO partnerships and showcase its production capabilities.

Lotte Biologics Unveils Dual-Site Strategy: A Game Changer for Global CDMO in 2027

Lotte Biologics aims to lead in the evolving biotech landscape with dual sites in the U.S. and South Korea, enhancing global supply chains.

Top News

- Our Sponsors Ad -

Follow us